Showing results (51-60 of 622) with videos related to

Sort By:
Pageof 63
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
Fully Automated, High-Dose Radiosynthesis of [18F]PARPiAnna Pacelli, Fadi Zarrad, Wolfgang P Fendler, et al.
European Journal of Clinical Investigation|May 17, 2023
Prognostic role of early prostate specific antigen changes after [177 Lu]Lu-PSMA radioligand therapy of metastasized prostate cancer: A meta-analysisLuca Giovanella, Maria Luisa Garo, Marco Cuzzocrea, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 11, 2024
Cost-Effectiveness and Budget Impact Analyses of Selective Internal Radiation Therapy versus Atezolizumab Plus Bevacizumab from a German Statutory Health Insurance PerspectiveBjoern Schwander, Katharina Klesper, Siegbert Rossol, et al.
PET Clinics|May 10, 2016
Alternative PET Tracers in Musculoskeletal DiseaseAkram Al-Ibraheem, Andreas K Buck, Ambros J Beer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 2017
177Lu-PSMA Radioligand Therapy for Prostate CancerWolfgang P Fendler, Kambiz Rahbar, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 16, 2017
Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer RecurrenceJeremie Calais, Wolfgang P Fendler, Ken Herrmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
CXCR4 Ligands: The Next Big Hit?Annemiek M E Walenkamp, Constantin Lapa, Ken Herrmann, et al.
Clinical Nuclear Medicine|March 26, 2014
Differentiation of an unclear splenic lesion in a patient with cholangiocarcinomaConstantin Lapa, Ulrich Steger, Christian O Ritter, et al.
Clinical Nuclear Medicine|August 19, 2015
Localization of Parathyroid Adenoma With Real-Time Ultrasound: Freehand SPECT FusionChristina Bluemel, Paul Kirchner, Georg W Kajdi, et al.
Nuclear Medicine Communications|March 9, 2018
Pretherapeutic 124I dosimetry reliably predicts intratherapeutic blood kinetics of 131I in patients with differentiated thyroid carcinoma receiving high therapeutic activitiesMarcus Ruhlmann, Wilfried Sonnenschein, James Nagarajah, et al.
Pageof 63